Category: Joint ventures/collaborations
-
New Venture Fund Backs Underserved, Academic Start-Ups
A new $300 million venture capital fund is underway that aims to support technology start-ups often left behind by larger mainstream investors.
-
Biotech, UK Govt to Design Covid-19 Variant Vaccines
A biotechnology company and a U.K. government agency agreed to quickly develop and produce vaccines to protect against emerging Covid-19 viral mutations.
-
One-Dose Covid-19 Vaccine Shown to Prevent Hospitalization
Results from four international clinical trials show high disease prevention rates from one dose of the Oxford-AstraZeneca Covid-19 vaccine.
-
Cancer Immunotherapy Adapted for HIV
A biotechnology company is adapting and licensing its immunotherapy process, originally designed for cancer, as a cure for HIV infections.
-
Institutions Join Global Health Breakthrough Network
Wellcome Leap aims to establish a model for faster design and development of health breakthroughs, beginning with elimination of administrative obstacles.
-
Trial Testing Multi-Company Covid-19 Therapy
A clinical trial already underway is expanding to test a combination of two synthetic antibodies from different companies as a treatment for Covid-19 infections.
-
Patient Database Offered for Covid-19 Research Group
A large health care system is offering data from its Covid-19 patient registry to a consortium of government and academic research labs.
-
CubeSats to Test Satellite Group Signaling
A university robotics lab built three small space satellites for NASA to test radio transmissions in autonomous groups or swarms for more sophisticated future missions.
-
Antibodies Prevent Covid-19 Symptoms in Long-Term Care
A clinical trial shows long-term care residents and staff receiving a synthetic antibody treatment have a lower risk of getting symptomatic Covid-19 infections.
-
Multi-Variant Covid-19 Vaccine in the Works
A vaccine protecting against multiple Covid-19 viral variations is in development, with an early-stage clinical trial expected to begin soon.